Aggressive’ Bullish Options Activity Seen in ProShares Trust UltraPro Short QQQ ETF

 Aggressive' Bullish Options Activity Seen in ProShares Trust UltraPro Short QQQ ETF

In today’s session ProShares Trust UltraPro Short QQQ ETF (SQQQ) registered an unusually high (188) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the October, 2016 call, expecting serious SQQQ increase. With 188 contracts traded and 48584 open interest for the Oct, 16 contract, it seems this is a quite bullish bet. The option with symbol: SQQQ161021C00014000 closed last at: $0.2 or 20% down. About 1.83M shares traded hands. ProShares Trust UltraPro Short QQQ ETF (NASDAQ:SQQQ) has declined 36.23% since March 7, 2016 and is downtrending. It has underperformed by 43.82% the S&P500.

ProShares UltraPro Short QQQ seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The ETF has a market cap of $647.31 million. The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market. It currently has negative earnings. The Fund invests in derivatives.

More notable recent ProShares Trust UltraPro Short QQQ ETF (NASDAQ:SQQQ) news were published by: Fool.com which released: “Which Nasdaq ETF is Right for You?” on June 05, 2015, also Etfdailynews.com with their article: “The Best ETFs For A Stock Market Sell-Off” published on March 26, 2013, Etftrends.com published: “Inverse ETFs for a Market Sporting Warning Signs” on March 27, 2015. More interesting news about ProShares Trust UltraPro Short QQQ ETF (NASDAQ:SQQQ) were released by: Benzinga.com and their article: “ProShares Releases 2 New Leveraged Biotech ETFs” published on June 23, 2015 as well as Etfdailynews.com‘s news article titled: “ProShares Announces ETF Share Splits and Reverse Splits” with publication date: January 13, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment